World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01515631
Date of registration: 18/01/2012
Primary sponsor: Stanford University
Public title: Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review
Scientific title:
Date of first enrolment: April 2007
Target sample size: 25
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01515631
Study type:  Observational
Study design:  Observational Model: Case-Only, Time Perspective: Retrospective  
Countries of recruitment
United States
Contacts
Name:   Jeffrey Feinstein, MD, MPH
Address: 
Telephone: 650 723 7913
Email: jaf@stanford.edu
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of Alagille Syndrome

Exclusion Criteria:

- None



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Alagille Syndrome
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
AG9031
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history